Cancers | Free Full-Text | Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label,
Mustafa ÖZGÜROĞLU | Professor (Full) | professor | İstanbul University-Cerrahpaşa, Istanbul | Internal Medicine Division of Medical Oncology Clinical Trial Unit | Research profile
Jinekolojik Kanserlerde Tedavi | Nadir Kitap
Mustafa Özgüroğlu - Professor of Medical Oncology - Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine | LinkedIn
Breast carcinoma metastasis to endometrial polyp (Case report and literature review)
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO) - Lung Cancer
Sapanca Onkoloji Günleri - Türk Tıbbi Onkoloji Derneği
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre
KANSER KEMOTERAPİSİ UYGULAMA İLKELERİ, Fuat H. Demirelli Mustafa Özgüroğlu Gökh - İkinci El Kitap - kitantik | #4522107000297
Prof. Jair Bar | Tel Aviv University
Prof. Dr. Mustafa Özgüroğlu Yorumlarını oku ve randevu al - Doktorsitesi.com
Immunotherapy and Targeted Therapies in NSCLC: Phase 3 Data From ESMO 2022 - Cancer Therapy Advisor
Mustafa Özgüroğlu (mzgrolu) - Profile | Pinterest
Immunotherapy and Targeted Therapies in NSCLC: Phase 3 Data From ESMO 2022 - Cancer Therapy Advisor
Mustafa Özgüroğlu Özel Muayenehanesi, Şişli / İstanbul | Hekimler.Net
Title of the study: Phase II Clinical Study Evaluating the Efficacy and Safety of Weekly Docetaxel and Four Weekly Carboplat
İstanbul Üniversitesi - Cerrahpaşa | Hasan Ali Yücel Eğitim Fakültesi Pedagojik Formasyon Sertifika Programları
Akademik | Prof.Dr.Gökhan Demir
